Acute flaccid paralysis in children is a medical emergency that can progress to respiratory failure within hours or days, ...

Valley man spreading awareness about Guillain-Barré Syndrome Guillain-Barré Syndrome is a condition that attacks a person's nerves. It can lead to muscle weakness and sometimes paralysis.

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual MeetingFirst Oral Presentation of the ...

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005 ...

River Hill girls lacrosse’s Gabby Bergstrom overcomes Guillain-Barré Syndrome In January, the senior wasn’t sure if she’d ever play again. Now, she’s back on the field.

As it advances a monoclonal antibody targeting Guillain-Barré syndrome, Annexon is embarking on another effort to improve treatment of the condition.

About Guillain-Barré Syndrome GBS is a rare neuromuscular emergency resulting from an acute autoantibody and classical complement-mediated attack on peripheral nerves that generally occurs ...

CIDP is often considered the chronic form of Guillain-Barré Syndrome and, as such, can be more problematic in that it lasts longer, causes more damage and is more difficult to recover from.

Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis. Qatar pushes back on reports of $400M Boeing jet gift to Trump How to hard boil eggs ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.

Keywords: Guillain-Barré syndrome, hepatitis B virus, mechanical ventilation, predictors, risk factors Citation: Zhang W, Yao Q, Wang Y, Yin J and Yang X (2025) Clinical study of the relationship ...

A phase 3 trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a case of neurological disorder.